EASY yields 0.37% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, EASY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EASY + JNJ for your $10,000?
EASY invests in US large-cap companies with long records of paying and raising dividends, emphasizing businesses the Adviser defines as recession resistant. These are firms with steady demand for their products or services even during downturns, supported by low demand elasticity, recurring revenues, and high switching costs. They also typically show lower earnings volatility, more stable cash flows and less sensitivity to business cycles. EASYs approach combines top-down sector analysis with company-level screening to identify candidates with sustainable dividend policies and moderate to low revenue variability. The portfolio tends to tilt toward sectors such as consumer staples, utilities, pharmaceuticals, and technology but retains flexibility to adjust exposures as market conditions evolve. By focusing on companies with a demonstrated ability to maintain dividend growth through economic cycles, the fund seeks to balance capital appreciation with reliable income.
Full EASY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.